← Eichor
Study identifier: NCT01257269 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Condition: Thrombotic Thrombocytopenic Purpura · Congenital Thrombotic Thrombocytopenic Purpura · Familial Thrombotic Thrombocytopenic Purpura  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhaseN/A
Planned participants450
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Hereditary thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) is a rare disorder characterized by thrombocytopenia as a result of platelet consumption, microangiopathic hemolytic anemia, occlusion of the microvasculature with von Willebrand factor-platelet-thrombic and ischemic end organ damage. The underlying patho-mechanism is a severe congenital ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, 13) deficiency which is the result of compound heterozygous or homozygous ADAMTS13 gene mutations. Although considered a monogenic disorder the clinical presentation in Upshaw-Schulman syndrome patients varies considerably without an apparent genotype-phenotype correlation. In 2006 we have initiated a registry for patients with Upshaw-Schulman syndrome and their family members to identify possible triggers of acute bouts of TTP, to document individual clinical courses and treatment requirements as well as possible side effects of long standing plasma substitution, e.g. alloantibody formation or viral infections.

This description comes directly from the study's public registry record.

Talk to the study team

Johanna A Kremer Hovinga, MD  ·  +41 31 632 02 65  ·  johanna.kremer@insel.ch

Marissa Schraner, Ph.D.  ·  +41 31 632 56 90  ·  marissa.schraner@insel.ch

Always discuss trial participation with your own doctor first.

Locations (7)

University of Oklahoma Health Sciences Center, Department of Medicine, PO Box 26901Oklahoma City, Oklahoma, United StatesRecruiting
Medical University of Vienna, Department of Medicine 1, Div. Hematology and Hemostasis Waehringer Guertel 18-20Vienna, AustriaRecruiting
Institute of Hematology and Blood Transfusion, Coagulation Laboratory, U nemocnice 1Prague, CzechiaRecruiting
University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Martinistr 52Hamburg, GermanyNot Yet Recruiting
Nara Medical University, Department of Blood Transfusion Medicine, Shijyo-cho 840Kashihara, Nara, JapanRecruiting
Trondheim University St Olavs Hospital, Department of Hematology, PO Box 3250 SluppenTrondheim, NorwayRecruiting
University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, InselspitalBern, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01257269